Jeanne Magram, Ph.D.

Jeanne Magram, Ph.D.

Chief Scientific Officer

Dr. Magram brings to Celsius more than 25 years of drug discovery and development experience. Prior to Celsius, she was chief scientific officer of Quentis Therapeutics, a company focused on addressing the impact of cellular stress on immune suppression within the tumor microenvironment. Previously, Dr. Magram was the founding chief scientific officer of Northern Biologics, a company focused on first-in-class biologics for solid tumors. Prior to Northern Biologics, she served as the site head for Pfizer’s Centers for Therapeutic Innovation, a partnership between Pfizer and academic medical centers designed to accelerate the translation of innovative discoveries into differentiated new medicines. Before that, Dr. Magram was vice president, immunology & inflammation research at Boehringer Ingelheim, where she oversaw a department committed to drug discovery in autoimmune disease. In this role, she delivered several candidates into preclinical and clinical testing, including the recently approved therapy SKYRIZI. Earlier in her career, Dr. Magram was an associate director of G protein-coupled receptor (GPCR) drug discovery at OSI Pharmaceuticals and held roles at Hoffmann-La Roche focused on using model systems to understand the pathophysiology of disease and to identify new therapies.

Dr. Magram completed her postdoctoral training in the laboratory of Nobel Laureate J. Michael Bishop and obtained her Ph.D. in the laboratory of Franklin Costantini, Ph.D., in the Department of Genetics and Development at Columbia University Irving Medical Center.